Home/Filings/4/0000905148-23-001449
4//SEC Filing

DOBMEIER ERIC 4

Accession 0000905148-23-001449

CIK 0001604464other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 6:27 PM ET

Size

4.7 KB

Accession

0000905148-23-001449

Insider Transaction Report

Form 4
Period: 2023-11-10
Transactions
  • Purchase

    Common Stock

    2023-11-10$0.23/sh+446,825$101,340563,325 total
Footnotes (1)
  • [F1]Represents the weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.2235 to $0.2298. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

Documents

1 file

Issuer

Atara Biotherapeutics, Inc.

CIK 0001604464

Entity typeother

Related Parties

1
  • filerCIK 0001202785

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 6:27 PM ET
Size
4.7 KB